Lexicon Pharmaceuticals, Inc.
Lexicon Pharmaceuticals, Inc.
LXRX
Valuace
70
Růst
63
Zdraví
75
Cena
$ 1.36
Dnes
+0.09 (7.03%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
0.5B
Obrat
0B
Zisk
0B
Aktiva
0B
Dluh
0B
ROE
-57%
ROA
-33%
PE
-11
PS
11
Cena 1R
0-2
⌀ Cena
1.07
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
05-03-2026
Poslední dividenda

Profil

Lexicon Pharmaceuticals, Inc., biofarmaceutická společnost, se zaměřuje na objevování, vývoj a komercializaci farmaceutických výrobků. Jeho perorálně podávané malé molekuly léků, které jsou ve vývoji, zahrnují Sotagliflozin, který dokončil klinické studie fáze III pro léčbu srdečního selhání a diabetu typu 1, a LX9211, který je ve fázi II klinického vývoje pro léčbu neuropatické bolesti. Společnost má strategickou spolupráci a licenční smlouvy se společností Bristol-Myers Squibb Company a Genentech, Inc. Lexicon Pharmaceuticals, Inc. byla založena v roce 1995 a sídlí v texaském Woodlands.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
103
Založení
2000-04-07
Adresa
2445 Technology Forest Boulevard
CEO
Michael S. Exton

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 2025202420232022202120202019201820172016201520142013201220112010
Total Revenues49.849.831.11.20.10.324.0322.163.290.383.3130.022.92.21.11.84.9
Cost of Revenues0.60.30.60.10.00.01.93.22.51.90.00.00.00.00.00.00.0
Gross Profit49.249.530.51.10.10.322.1318.860.788.483.3130.022.92.21.11.84.9
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues5.514.228.91.326.61.81.61.10.70.2
Cost of Revenues0.30.00.20.025.90.10.20.20.20.0
Gross Profit5.214.228.71.20.61.71.51.00.50.2
Operating Income TTM 2025202420232022202120202019201820172016201520142013201220112010
R&D Expenses0.00.00.058.952.855.0153.691.9100.2156.8178.295.289.389.782.691.875.4
Selling General & Admin Expenses0.00.00.0114.048.132.347.256.863.866.243.023.819.417.117.017.422.6
Depreciation & Amortization0.60.60.50.61.60.12.832.03.73.42.10.71.92.94.24.95.4
Total Operating Expenses98.198.4227.6172.9100.987.4200.9148.8164.0223.0221.2119.0108.7106.899.6115.9100.6
Operating Income-48.9-48.9-197.1-171.8-100.8-87.1-178.8141.4-103.3-136.7-137.21.5-100.4-102.4-108.4-114.1-95.7
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.00.00.00.00.00.00.00.014.617.6
Selling General & Admin Expenses0.00.00.00.00.00.00.00.032.632.2
Depreciation & Amortization0.10.20.20.20.10.10.10.10.10.2
Total Operating Expenses20.026.424.926.933.465.456.846.347.249.8
Operating Income-14.8-12.23.7-25.7-32.7-63.7-55.4-45.3-46.7-49.6
Net Income TTM 2025202420232022202120202019201820172016201520142013201220112010
Interest Income6.96.912.37.71.60.12.83.43.52.02.30.62.30.20.20.30.5
Interest Expense8.38.315.613.12.80.814.520.720.87.06.66.72.32.02.12.52.7
Other Expense-1.4-1.4-3.3-5.4-1.2-0.7120.2-17.3-17.3-2.10.7-9.5-14.52.3-9.80.2-3.9
IBT-50.3-50.3-200.4-177.1-101.9-87.8-58.6124.1-120.5-141.7-141.4-4.7-100.4-104.1-110.2-116.2-101.8
Income Tax Expense0.00.00.00.01.20.511.6-6.03.5-12.74.56.0-0.1-0.8-2.0-2.40.0
Net Income-50.3-50.3-200.4-177.1-103.1-88.3-70.2130.1-120.5-129.1-141.4-4.7-100.3-104.1-110.2-116.2-101.8
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income1.31.61.82.22.83.44.11.92.43.0
Interest Expense2.02.22.31.83.94.62.24.95.43.9
Other Expense-0.8-0.6-0.50.4-1.0-1.11.9-3.1-3.0-0.9
IBT-15.5-12.83.3-25.3-33.8-64.8-53.4-48.4-48.2-50.5
Income Tax Expense0.00.00.00.00.00.00.00.0-3.02.9
Net Income-15.5-12.83.3-25.3-33.8-64.8-53.4-48.4-48.2-50.5
Per Share Data TTM 2025202420232022202120202019201820172016201520142013201220112010
EPS$0.00$0.00$0.00$-0.80$-0.62$-0.61$-0.63$1.23$-1.14$-1.23$-1.36$-0.05$-1.31$-1.42$-1.58$-2.39$-2.35
EPS Diluted$0.00$0.00$0.00$-0.80$-0.62$-0.61$-0.63$1.16$-1.14$-1.23$-1.36$-0.05$-1.31$-1.42$-1.58$-2.39$-2.35
Shares Outstanding363.4363.1320.0221.1165.7145.7110.8106.2105.8105.2103.9103.676.373.370.048.743.3
Diluted Shares Outstanding363.4363.1320.0221.1165.7145.7110.8116.7105.8105.2103.9103.676.373.370.048.743.3
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.20$-0.21
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.20$-0.21
Shares Outstanding363.4363.4363.3362.1361.5361.5310.8245.4244.9244.9
Diluted Shares Outstanding363.4363.4363.6362.1361.5361.5310.8245.4244.9244.9
Current Assets TTM 202420232022202120202019201820172016201520142013201220112010
Cash And Equivalents35.666.722.546.364.1126.336.1160.1310.8346.5521.4339.3129.1223.2281.747.2
Short Term Investments274.3171.3147.692.022.726.0235.579.7249.1299.9318.4202.191.6192.895.4163.9
Total Cash & ST Investments310.0238.0170.0138.486.7152.3271.7160.1310.8346.5521.4339.3129.1223.2281.7211.1
Accounts Receivable2.63.51.00.00.00.456.55.94.87.50.91.00.81.40.40.7
Inventory0.60.20.40.00.00.04.24.71.90.00.04.80.00.0-4.10.0
Other Current Assets7.74.55.12.52.25.05.32.74.43.910.123.84.66.33.72.9
Total Current Assets320.8246.2176.5140.988.9157.7337.8173.3322.0357.9532.4369.0134.6230.9281.7214.7
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents49.721.462.966.734.635.696.522.521.1102.3
Short Term Investments66.3117.6132.0171.3223.8274.3259.1147.6197.3154.5
Total Cash & ST Investments116.0139.0194.8238.0258.4310.0355.6170.0218.4256.7
Accounts Receivable2.32.247.43.52.92.61.51.00.30.7
Inventory0.20.20.20.20.60.60.50.40.30.2
Other Current Assets4.13.73.34.56.77.77.05.14.36.1
Total Current Assets122.5145.1245.8246.2268.6320.8364.6176.5223.4263.7
Long-Term Assets TTM 202420232022202120202019201820172016201520142013201220112010
Net Property, Plant & Equipment7.17.37.52.11.20.314.015.917.719.421.21.141.442.646.453.4
Goodwill44.544.544.544.544.544.544.544.544.544.544.544.544.544.544.544.5
Intangible Assets0.00.00.00.00.00.019.750.151.953.453.453.453.653.653.653.6
Long-Term Investments0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Other Long-Term Assets0.80.40.86.82.31.21.70.30.40.53.33.40.10.14.30.6
Total Long-Term Assets52.552.252.953.448.046.180.0110.8114.5117.8122.4102.4139.6140.8148.8152.1
Total Assets373.4298.4229.4194.3136.9203.8417.7284.1436.5475.6654.8471.4274.2371.8430.5366.9
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment9.56.67.07.37.17.17.27.52.18.5
Goodwill44.544.544.544.544.544.544.544.544.544.5
Intangible Assets0.00.00.00.00.00.00.00.00.00.0
Long-Term Investments0.00.00.00.00.00.00.00.00.00.0
Other Long-Term Assets29.429.40.40.40.80.80.80.86.4-53.0
Total Long-Term Assets83.480.551.952.252.552.552.652.953.153.0
Total Assets205.9225.6297.7298.4321.1373.4417.2229.4276.5316.7
Current Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Accounts Payable12.214.814.410.49.25.512.217.857.752.919.713.19.77.76.03.2
Short-Term Debt1.31.21.31.31.112.211.01.114.116.32.020.21.71.624.91.1
Other Current Liabilities14.429.315.911.511.91.042.214.512.332.124.810.17.78.9-6.26.3
Current Liabilities27.945.231.523.222.146.865.336.8124.1164.6123.045.019.318.324.910.8
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable3.85.910.714.814.212.28.114.412.010.5
Short-Term Debt1.60.943.11.21.31.31.31.31.31.3
Other Current Liabilities12.010.611.929.320.514.414.015.918.914.3
Current Liabilities21.734.8110.745.236.027.923.431.532.326.1
Long-Term Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Long-Term Debt99.5107.2104.854.01.20.6235.3243.9231.685.2103.887.520.221.923.528.5
Capital Leases4.98.15.36.72.31.21.10.00.00.00.00.00.00.00.00.0
Def. Tax Liability0.00.00.00.00.00.00.06.06.018.718.718.718.718.718.718.7
Total Liabilities133.4152.5136.377.223.347.4300.6310.5384.4318.2369.0187.4104.0105.1132.9119.9
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt56.556.158.6107.299.9104.4105.0104.8104.7104.3
Capital Leases1.60.91.08.11.34.95.15.36.76.8
Def. Tax Liability0.00.00.00.00.00.00.00.00.00.0
Total Liabilities85.896.1174.6152.5142.6133.4128.4136.3137.0130.4
Total Common Equity TTM 202420232022202120202019201820172016201520142013201220112010
Common Stock0.40.40.20.20.20.10.10.10.10.10.10.70.50.50.50.3
Retained Earnings-1,868.7-1,967.2-1,766.8-1,589.7-1,487.8-1,400.0-1,341.4-1,471.6-1,381.4-1,250.4-1,108.9-1,104.3-1,004.0-899.8-789.6-673.4
Comprehensive Income-0.20.10.0-0.40.00.00.10.0-0.2-0.2-0.2-0.10.00.00.00.0
Total Common Equity240.0146.093.1-1,589.7-1,487.8156.4-1,341.4-1,471.652.1157.4285.9284.0-1,004.0266.7297.6247.0
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock0.40.40.40.40.40.40.20.20.20.2
Retained Earnings-2,002.1-1,989.3-1,992.5-1,967.2-1,933.5-1,868.7-1,815.2-1,766.8-1,717.1-1,666.6
Comprehensive Income0.00.00.00.10.3-0.2-0.10.0-0.1-0.1
Total Common Equity120.2129.4123.0146.0178.5240.0288.993.1-1,717.1-1,666.6
Other TTM 202420232022202120202019201820172016201520142013201220112010
Total Debt105.7108.4106.155.32.312.8246.3245.0245.7101.4105.8107.721.923.524.928.5
Book Value240.0146.093.1117.1113.6156.4117.1-26.452.1157.4285.9284.0170.2266.7297.6247.0
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.00.00.00.00.00.00.00.00.00.0
Book Value120.2129.4123.0146.0178.5240.0288.993.1-1,717.1-1,666.6
Cash Flow From Operating Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Income-200.6-50.3-200.4-177.1-101.9-87.8-58.6130.1-120.5-129.1-141.4-4.7-100.3-104.1-110.2-116.2-101.8
Depreciation & Amortization0.60.60.50.60.40.32.93.73.73.42.10.71.92.94.24.95.4
Stock-Based Compensation16.312.513.514.311.510.613.314.211.79.57.56.87.17.46.55.75.5
Change Working Capital-3.6-26.914.22.70.4-10.231.1-58.3-44.8-59.3-43.5171.92.35.0-4.810.21.0
Change In Accounts Receivable-1.91.1-2.5-1.00.00.453.2-50.6-1.10.2-4.10.10.50.6-1.00.00.0
Change In Accounts Payable0.3-30.214.86.50.1-14.2-21.020.1-18.9-7.227.76.21.33.1-1.010.4-5.2
Change In Inventories-0.4-0.10.2-0.40.00.00.30.4-2.7-1.96.2-5.8-0.11.7-2.50.00.0
Other Non-cash Items13.2-3.8-6.6-2.30.70.1-131.630.11.32.7-0.26.413.4-2.29.9-109.42.7
Cash from Operations-195.80.00.0-161.9-88.9-87.0-143.0113.8-148.6-185.4-175.6184.8-75.6-91.1-94.5-87.9-82.4
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income-15.5-12.83.3-25.3-33.8-64.8-53.4-48.4-48.2-50.5
Depreciation & Amortization0.10.20.20.20.10.10.10.10.10.2
Stock-Based Compensation2.80.03.23.01.50.04.94.33.23.9
Change Working Capital-4.5-14.311.2-19.211.89.74.3-11.5-4.37.9
Change In Accounts Receivable-0.1-0.20.31.0-0.6-0.3-1.1-0.5-0.70.4
Change In Accounts Payable-5.6-14.011.1-21.79.18.95.9-9.1-2.76.1
Change In Inventories-0.10.00.00.00.4-0.1-0.1-0.10.0-0.2
Other Non-cash Items-0.13.1-0.8-2.5-1.21.4-4.40.35.5-3.0
Cash from Operations0.00.00.00.00.00.00.00.0-50.5-41.6
Cash Flow From Investing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Capital Expenditure-0.30.0-1.0-0.5-1.3-1.2-0.1-0.1-0.1-0.2-0.2-0.9-0.1-1.7-0.5-1.2-1.1
Acquisitions-62.10.00.00.00.00.011.00.00.00.00.00.00.00.00.00.0-5.6
Investments-332.6-143.6-338.1-223.3-133.9-34.3-58.6-322.4-120.0-267.9-425.7-326.4-222.0-111.5-233.3-108.1-155.9
Sales of Investment223.0252.9314.4173.964.237.6268.0166.6289.7318.6444.2210.0111.4212.6135.9176.648.6
Other Investing Activities-109.60.00.00.00.00.0160.40.00.00.00.00.32.20.10.12.60.1
Cash from Investing-110.00.00.0-49.9-71.12.1380.8-155.9169.650.518.3-117.0-108.499.5-97.870.0-113.8
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure0.00.00.00.0-0.5-0.3-0.30.00.0-0.1
Acquisitions0.00.00.00.00.00.00.00.0-101.439.2
Investments-22.6-26.7-27.2-66.3-25.8-42.6-77.1-183.2-0.1-72.2
Sales of Investment27.078.941.5105.680.096.465.073.052.033.0
Other Investing Activities0.00.00.00.00.00.00.00.051.9-39.2
Cash from Investing0.00.00.00.00.00.00.00.051.9-39.3
Cash Flow From Financing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Debt Repaid0.00.00.050.0-48.9-11.7-216.6-1.3-14.5-2.3-2.0-1.9-1.7-1.6-1.4-3.6-49.9
Debt Issued0.1108.42.3100.7101.91.2-16.92.613.9146.5-2.30.087.50.00.00.078.3
Issuance of Common Stock241.30.00.0138.894.237.170.00.00.78.03.60.1202.31.138.1160.8181.5
Repurchase of Common Stock-1.70.0-1.7-0.8-0.9-2.7-1.0-0.9-1.0-1.7-0.6-0.4-0.9-0.9-0.3-0.1-0.1
Dividends Paid0.00.00.00.00.0-11.7-216.60.00.00.0-2.00.00.00.0-1.4-3.60.0
Other Financing Activities-0.60.00.00.097.711.7216.60.012.5145.92.00.184.10.01.43.611.4
Cash from Financing239.20.00.0188.0142.222.7-147.6-2.2-2.2149.91.0-2.0283.8-1.436.4157.1142.9
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.00.00.00.00.00.00.00.00.00.0
Debt Issued58.21.1-44.7-6.77.2-4.5-0.60.20.10.5
Issuance of Common Stock0.00.00.00.00.00.00.00.00.0-0.2
Repurchase of Common Stock0.00.00.00.00.00.00.00.00.20.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.0
Other Financing Activities0.00.00.00.00.00.00.00.00.00.0
Cash from Financing0.00.00.00.00.00.00.00.00.0-0.2
Cash position TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Change in Cash-66.7-3.344.2-23.9-17.7-62.290.2-44.318.715.1-156.465.799.87.1-155.9139.1-53.3
Closing Cash Balance35.663.366.722.546.364.1126.336.180.461.746.6203.0137.337.530.4186.347.2
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash-15.328.3-12.5-3.832.1-1.1-60.974.01.3-81.2
Closing Cash Balance63.349.750.462.966.734.635.696.522.521.1
Free Cash Flow TTM 2025202420232022202120202019201820172016201520142013201220112010
Free Cash Flow-196.2-67.9-179.8-162.4-90.2-88.2-143.1113.7-148.7-185.6-175.9183.9-75.7-92.8-95.0-89.1-83.5
Real Free Cash Flow-212.4-80.4-193.3-176.7-101.7-98.8-156.399.5-160.4-195.1-183.3177.0-82.8-100.2-101.4-94.9-89.0
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow-17.2-23.817.0-43.8-22.0-53.9-48.8-55.1-50.5-41.7
Real Free Cash Flow-20.1-23.813.8-46.8-23.5-53.9-53.6-59.4-53.8-45.6
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-11.3-14.2-1.4
P/S11.4467.59.4
P/B4.7-0.75.2
P/FCF-7.4-4.8-1.5
Market cap$0.5$0.5
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets28.2 %27.1 %0 %
Debt to Income-115.5 %-106.1 %0 %
Debt to Free cash flow-75.6 %-329.8 %0 %
Interest expense percentage-17 %-1.9 %44.7 %
Current ratio5.6 6.4 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE-41.9 %7.9 %0 %
ROA-24.4 %-32.4 %0 %
CapEx to Revenue0.7 %87.6 %0 %
RaD to Revenue0 %5617.6 %0 %
ROEM483,524.3 214335.6

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin63.1 %96.6 %68.7 %
Operating margin-94.4 %-9652.3 %35.5 %
Net margin-96.8 %-9825.3 %9.5 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0 %0 %
Dividend payout percentage0 %-0.2 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding363.4 mil 128.6 mil
Employee count0.1 tis 0.3 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader